Delivery Order SPE2DB20D7066-SPE2DB24FC2FR
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,045.64 firm fixed-price delivery order is for the supply of 200 mg/20 ml Ketamine vials. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract award, valued at $1,421.76, is for the delivery of KETAMINE 500 MG/5 ML VIAL 5ML medical supplies. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical, which provides a comprehensive range of...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,432.20 firm fixed-price contract is for the delivery of 200 mg/20 mL vials of the drug Ketamine. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of 200 mg/20 ml vials of the drug ketamine. The contract has a ceiling value of $3,191.63 and a completion date of May 20, 2025. It is a firm fixed-price contract with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is the prime contractor and holds a larger $999,999,999.00 Indefinite...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,059 firm-fixed-price delivery order is for the supply of 4,566,134,691 units of Ketamine 500 mg/5 ml vials. The contract has an ultimate completion date of October 18, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
- This federal contract award, with ID SPE2DB22D2206|SPE2DB25FGL00, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of 500 mg/5 ml ketamine vials. The fixed-price delivery order has a ceiling value of $2,870.75 and a completion date of April 8, 2025. The contract is not designated as a set-aside and represents an open competition award. Amerisourcebergen Drug Corp is the prime contractor and holds a significant...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,346.00 firm fixed-price delivery order is for the procurement of 4567475769 - KETAMINE 500 MG/5 ML VIAL 5ML. The award is not designated as a set-aside contract. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the delivery of 4566513085 - KETAMINE 200 MG/20 ML VIAL 20ML. The Firm Fixed Price contract has a ceiling value of $1,079.37 and an ultimate completion date of November 22, 2024. This contract represents a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 between AmerisourceBergen and the DLA Troop Support Medical, which expires in November 2026....
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,037.55 firm-fixed-price delivery order is for the supply of Ketalar (ketamine hydrochloride) 200 mg/20 ml vials with a period of performance through November 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
- This federal contract award, with ID SPE2DB25D3201|SPE2DB25FNQZJ, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4567198100 - KETAMINE 200 MG/20 ML VIAL 20ML, with a ceiling value of $4,034.60 and a period of performance through February 10, 2025. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen...
- SPE2DB20D7066Indefinite Delivery Contract
- SPE2DB20D7066-SPE2DB24FC2FRDelivery Order
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,052.47 firm fixed-price delivery order contract is for the supply of Ketamine 200 mg/20 ml vials. The contract does not have a set-aside designation, indicating open competition. It is associated with a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract encompasses critical medical commodities including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.1k | 6/7/24 |